Nath Bio-Genes (I) logo

NATHBIOGEN - Nath Bio-Genes (I) Share Price

₹364.35 9.5  2.7%

Last Trade - 04/08/20

Sector
Consumer Defensives
Size
Small Cap
Market Cap £70.5m
Enterprise Value £75.4m
Revenue £28.5m
Position in Universe 769th / 2996
Bullish
Bearish
Unlock NATHBIOGEN Revenue
Momentum
Relative Strength (%)
1m +9.80%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -6.60%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
1,853 1,621 1,697 1,917 2,309 2,799 3,258 3,714 +8.6%
+4.5 -44.2 +15.0 +75.4 +13.2 +31.2 +7.88 +11.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, Nath Bio-Genes (I) Ltd revenues increased 21% to RS2.8B. Net income increased 31% to RS504.8M. Revenues reflect Agriculture Activities segment increase of 17% to RS2.17B, Trading Activity segment increase of 48% to RS288.8M, India segment increase of 20% to RS2.74B, Outside India segment increase from RS28.8M to RS60.4M. Net income benefited from Rates and Taxes decrease of 81% to RS697K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

NATHBIOGEN Revenue Unlock NATHBIOGEN Revenue

Net Income

NATHBIOGEN Net Income Unlock NATHBIOGEN Revenue

Normalised EPS

NATHBIOGEN Normalised EPS Unlock NATHBIOGEN Revenue

PE Ratio Range

NATHBIOGEN PE Ratio Range Unlock NATHBIOGEN Revenue

Dividend Yield Range

NATHBIOGEN Dividend Yield Range Unlock NATHBIOGEN Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
NATHBIOGEN EPS Forecasts Unlock NATHBIOGEN Revenue
Profile Summary

Nath Bio-Genes (India) Limited is engaged in hybrid seed business. The Company is engaged in the business of production, processing and marketing of hybrid and genetically modified (GM) seeds. The Company’s segments include agricultural activities (seed production) and trading activities. Its products include field crops, cereals, fibre and oil seeds, vegetable crops and micro nutrient supplements. Its cereals range includes maize, paddy, pearl millet, wheat and jowar. It offers fiber and oils seeds, such as cotton, mustard and sunflower. Its nutritional supplements include Win-Chi-Win and Bio-Energy. Its vegetable crop range includes chilli, okra, tomato, bottle gourd, bitter gourd, cucumber and coriander. The Company has seed processing facilities with approximately 10 processing plants located in Maharashtra and Andhra Pradesh. It also has processing arrangements in Gujarat, Karnataka, Tamil Nadu, Madhya Pradesh and Rajasthan on custom basis.

Directors
Last Annual March 31st, 2020
Last Interim March 31st, 2020
Incorporated July 14, 1993
Public Since January 28, 2014
No. of Shareholders: 95
No. of Employees: n/a
Sector Consumer Defensives
Industry Food & Tobacco
Index
Exchange National Stock Exchange of India
Shares in Issue 19,004,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
NATHBIOGEN Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for NATHBIOGEN
Upcoming Events for NATHBIOGEN
Frequently Asked Questions for Nath Bio-Genes (I)
What is the Nath Bio-Genes (I) share price?

As of 04/08/20, shares in Nath Bio-Genes (I) are trading at ₹364.35, giving the company a market capitalisation of £70.5m. This share price information is delayed by 15 minutes.

How has the Nath Bio-Genes (I) share price performed this year?

Shares in Nath Bio-Genes (I) are currently trading at ₹364.35 and the price has moved by -1.9% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Nath Bio-Genes (I) price has moved by -3.59% over the past year.

What are the analyst and broker recommendations for Nath Bio-Genes (I)?

There are no analysts currently covering Nath Bio-Genes (I).

When will Nath Bio-Genes (I) next release its financial results?

Nath Bio-Genes (I) is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Nath Bio-Genes (I) dividend yield?

Nath Bio-Genes (I) does not currently pay a dividend.

Does Nath Bio-Genes (I) pay a dividend?

Nath Bio-Genes (I) does not currently pay a dividend.

When does Nath Bio-Genes (I) next pay dividends?

Nath Bio-Genes (I) does not currently pay a dividend.

How do I buy Nath Bio-Genes (I) shares?

To buy shares in Nath Bio-Genes (I) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Nath Bio-Genes (I)?

Shares in Nath Bio-Genes (I) are currently trading at ₹364.35, giving the company a market capitalisation of £70.5m.

Where are Nath Bio-Genes (I) shares listed? Where are Nath Bio-Genes (I) shares listed?

Here are the trading details for Nath Bio-Genes (I):

Country of listing: India
Exchange: NSI
Ticker Symbol: NATHBIOGEN
What kind of share is Nath Bio-Genes (I)?

Based on an overall assessment of its quality, value and momentum, Nath Bio-Genes (I) is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Nath Bio-Genes (I) share price forecast 2020?

We were not able to load any forecast data for Nath Bio-Genes (I).

How can I tell whether the Nath Bio-Genes (I) share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nath Bio-Genes (I). Over the past six months, the relative strength of its shares against the market has been 22.62%. At the current price of ₹364.35, shares in Nath Bio-Genes (I) are trading at 18.52% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Nath Bio-Genes (I) PE Ratio?

The Nath Bio-Genes (I) PE ratio based on its reported earnings over the past 12 months is 13.74. The shares are currently trading at ₹364.35.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Nath Bio-Genes (I)?

Nath Bio-Genes (I)'s management team is headed by:

Sweta Kagliwal - NED
Satish Kagliwal - MDR
Shrirang Agrawal - NED
Kashinath Iyer - IND
Omprakash Sharma - NED
Devinder Khurana - CFO
Dhiraj Rathi - CCO
Jeevanlata Kagliwal - DRC
Who are the major shareholders of Nath Bio-Genes (I)?

Here are the top five shareholders of Nath Bio-Genes (I) based on the size of their shareholding:

Authum Investments & Infrastructure Corporation
Percentage owned: 14.08% (2.68m shares)
Ashu Farms Pvt. Ltd. Corporation
Percentage owned: 10.99% (2.09m shares)
Akash Farms Pvt. Ltd. Corporation
Percentage owned: 10.75% (2.04m shares)
Mentor Capital, Ltd. Corporation
Percentage owned: 9.57% (1.82m shares)
Aditya Birla Sun Life AMC Limited Investment Advisor
Percentage owned: 8.53% (1.62m shares)
Similar to NATHBIOGEN
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.